(Q41719935)

8 October 2017

1 reference

title

Surfactant: a review of its functions and relevance in adult respiratory disorders (English)

1 reference

8 October 2017

3

1 reference

8 October 2017

Hamm H

1

1 reference

PubMed ID

9499810

8 October 2017

Kroegel C

series ordinal

2

1 reference

PubMed ID

9499810

8 October 2017

language of work or name

1 reference

1 May 1996

1 reference

8 October 2017

1 reference

8 October 2017

90

1 reference

8 October 2017

5

1 reference

8 October 2017

251-270

1 reference

Neue Auffassungen über einen Grundbegriff der Atemmechanik

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Properties, Function and Origin of the Alveolar Lining Layer

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant for the treatment of respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surface adsorption of pulmonary surfactant in relation to bulk-phase concentration and presence of CaCl2

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

1 reference

7 January 2021

The surfactant system of the adult lung: physiology and clinical perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surface tension induced by dipalmitoyl lecithinin vitrounder physiological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Metabolism and turnover of lung surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

A proposed nomenclature for pulmonary surfactant-associated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

The proteins of the surfactant system

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Lung surfactant-associated proteins and type IV collagen share common epitopes. An immunocytochemical demonstration

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant protein A is localized at the corners of the pulmonary tubular myelin lattice

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Sixty years of surfactant research

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

The role of surfactant-associated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Interactions of surfactant protein A with influenza A viruses: binding and neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Identification of surfactant proteolipid SP-B in human surfactant and fetal lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant protein B: disulfide bridges, structural properties and kringle similarities

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Function and regulation of expression of pulmonary surfactant-associated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant protein SP-B induces ordering at the surface of model membrane bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Structure-function relationships of bovine pulmonary surfactant proteins: SP-B and SP-C.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Pulmonary surfactant protein B (SP-B): structure-function relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro — comparison to natural surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Characterization of pulmonary surfactant protein D: its copurification with lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant proteins and SP-D.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant protein D (SP-D) counteracts the inhibitory effect of surfactant protein A (SP-A) on phospholipid secretion by alveolar type II cells. Interaction of native SP-D with SP-A

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant apoprotein A (SP-A) is synthesized in airway cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

The proximal border of the human respiratory unit, as shown by scanning and transmission electron microscopy and light microscopical cytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Chemical structure of phospholipids in the lungs and airways of sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Implication of surfactant apoprotein in otitis media with effusion

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

1 reference

7 January 2021

The pulmonary surfactant system: biochemical aspects and functional significance

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Hormonal regulation of pulmonary surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Regulation of lung surfactant secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Synthesis and assembly of lung surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Localization of Surfactant Protein Synthesis in Human Lung byIn SituHybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

In vivo regulation of surfactant proteins by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Distribution of surfactant protein A in rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Ventilation and secretion of pulmonary surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Degradation of pulmonary surfactant disaturated phosphatidylcholines by alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Specific interaction of lung surfactant protein A (SP-A) with rat alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Clearance of surfactant phosphatidylcholine via the upper airways in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Clearance of surfactant phosphatidylcholine from adult rabbit lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Characterization of antioxidant activities of pulmonary surfactant mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Human alveolar lining material and antibacterial defenses

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

The effect of pulmonary surface-active material on the generation and expression of murine B- and T-lymphocyte effector functions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Immunosuppression by pulmonary surfactant: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

ICAM-1 and integrin expression on isolated human alveolar type II pneumocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Class II molecules on rat alveolar type II epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Distribution of integrin cell adhesion receptors in normal and malignant lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Epidermal Growth Factor Transcription, Translation, and Signal Transduction by Rat Type II Pneumocytes in Culture

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Tumor necrosis factor-alpha-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Release of prostaglandins and thromboxanes by guinea pig isolated type II pneumocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Type II alveolar epithelial eicosanoid metabolism: predominance of cyclooxygenase pathways and transcellular lipoxygenase metabolism in co-culture with neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Fluid dynamics during bronchoalveolar lavage.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Bronchoalveolar lavage. Quantitation of intraalveolar fluid?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Composition of human pulmonary surfactant varies with exercise and level of fitness

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Changes in surfactant in bronchoalveolar lavage fluid after hemithorax irradiation in patients with mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Increased recovery of surfactant protein A in AIDS-related pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Decreased surfactant protein A in patients with bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Enzyme-linked immunosorbent assay for human pulmonary surfactant protein D

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant abnormalities in patients with respiratory failure after multiple trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Alterations of acidic phospholipids in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

High-performance liquid chromatographic analysis of phospholipids from different sources with combined fluorescence and ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

A captive bubble method reproduces the in situ behavior of lung surfactant monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

The acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Functional abnormalities of lung surfactant in experimental acute alveolar injury in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Altered alveolar surfactant is an early marker of acute lung injury in septic adult sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant treatment of respiratory failure induced by hydrochloric acid aspiration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant and the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Inactivation of Exogenous Surfactant by Pulmonary Edema Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Artificial pulmonary surfactant inhibited by proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Lung Surfactant Phospholipids Associate with Polymerizing Fibrin: Loss of Surface Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Changes of alveolar stability and phospholipids in pulmonary surfactant in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Acute lung injury induced by phospholipase A2. Structural and functional changes

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Inhibition of pulmonary surfactant function by phospholipases

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Exogenous surfactant therapy in ARDS. Lessons from the neonatal ICU

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant for adults with respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Successful treatment of ARDS with two doses of synthetic surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant analysis during Pneumocystis carinii pneumonia in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant Replacement Therapy Improves Pulmonary Mechanics in End-stage Influenza A Pneumonia in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Lung-restricted Activation of the Alveolar Macrophage/Monocyte System in Pulmonary Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant apoprotein-A concentration in sputum for diagnosis of pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Ultrastructure of lung in surfactant protein B deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Alterations in pulmonary surfactant composition and activity after experimental lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Role of pulmonary surfactant in airway closure: a computational study.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

1 reference

7 January 2021

Physiologic and toxicologic responses of alveolar type II cells

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Correlation of changes in pulmonary surfactant phospholipids with compliance in bleomycin-induced pulmonary fibrosis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Changes of lung surfactant and pressure-volume curve in bleomycin-induced pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Amiodarone- and desethylamiodarone-induced pulmonary phospholipidosis, inhibition of phospholipases in vivo, and alteration of [14C]amiodarone uptake by perfused lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Amiodarone--induced changes in surfactant phospholipids of rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Surfactant replacement in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

Levels of SP-A-anti-SP-A immune complexes in neonatal respiratory distress syndrome correlate with subsequent development of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990097-9

7 January 2021

10.1016/S0954-6111(96)90097-9

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9499810